The Healthy Aging and Senile Dementia progam project Neuropathology Core C has the Specific Aims of: (1) Assigning final neuropathologic diagnoses to all HASD subjects who come to autopsy (goal 25 new brains per year); (2) Performing brain autopsies on HASD subjects who give permission to do so, and to collect, store and distribute postmortem cerebrospinal fluid (CSF) and frozen brain tissue to program and other approved investigators to support research; (3) Maintaining electronic databases of neuropathology information that relates to autopsy examination, diagnosis, and tissue banking, in coordination with the Clinical and Biostatistics Cores; (4) Detecting and quantifying the full range of neuropathologic lesions associated with preclinical and overt dementia (senile plaques, neurofibrillary tangles, neuropil threads, argyrophilic grains, Lewy pathology, neuron loss, synaptic loss, tauopathic lesions, gliosis, etc.); and (5) to conduct developmental research using new histopathologic markers to promote diagnosis and to provide mechanistic insight into the causes and expression of dementing disorders compared to normal healthy aging and nondemented persons with preclinical Alzheimer disease (preclinical AD) brain lesions. * The Core leader McKeel, assisted by Senior Investigator Price and a well trained technical staff, have equipped the laboratory to process fixed brain tissue into paraffin blocks, to section these blocks at 6-10 microns, and to stain them with a variety of routine and special stains that include three silver methods (including Gallyas), thioflavine S, axon (modified Bielschowsky), and myelin stains (LFB-PAS). Immunohistochemical techniques are in place to detect a-beta amyloid, PHF type hyperphosphorylated tau, an Abeta-PHFtau dual stain to identify neuritic plaques with certainty, alpha-synuclein for synapses and Lewy pathology (neurites, pale bodies, brainstem and cortical Lewy bodies), ubiquitin, GFAP for astrocytic intermediate filaments, NeuN for neuron labeling, and synaptophysin for synapses. Dr. Price's laboratory will prepare 50 micron frozen sections of cytoarchitectonically defined brain regions (hippocampus, entorhinal cortex, cingulate cortex, gyrus rectus) for neuron counting using the Zeiss C.A.S.T. system. * This Core directly supports Projects 1-4 through it's Specific Aims, especially Aims 1, 3 and 5. Core brain lesion data will complement data obtained by the Clinical, Psychometric and Neuroimaging Cores.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG003991-21
Application #
6697809
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5 (M1))
Project Start
2004-01-01
Project End
2008-12-31
Budget Start
2004-01-01
Budget End
2004-12-31
Support Year
21
Fiscal Year
2004
Total Cost
$206,757
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Sutphen, Courtney L; McCue, Lena; Herries, Elizabeth M et al. (2018) Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease. Alzheimers Dement 14:869-879
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Lancour, Daniel; Naj, Adam; Mayeux, Richard et al. (2018) One for all and all for One: Improving replication of genetic studies through network diffusion. PLoS Genet 14:e1007306
Li, Zeran; Del-Aguila, Jorge L; Dube, Umber et al. (2018) Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure. Genome Med 10:43
Blaiotta, Claudia; Freund, Patrick; Cardoso, M Jorge et al. (2018) Generative diffeomorphic modelling of large MRI data sets for probabilistic template construction. Neuroimage 166:117-134
Schindler, Suzanne E; Sutphen, Courtney L; Teunissen, Charlotte et al. (2018) Upward drift in cerebrospinal fluid amyloid ? 42 assay values for more than 10 years. Alzheimers Dement 14:62-70
Gabel, Matthew; Gooblar, Jonathan; Roe, Catherine M et al. (2018) Political Ideology, Confidence in Science, and Participation in Alzheimer Disease Research Studies. Alzheimer Dis Assoc Disord 32:179-184
Blue, Elizabeth E; Bis, Joshua C; Dorschner, Michael O et al. (2018) Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project. Dement Geriatr Cogn Disord 45:1-17
Rao, Shuquan; Ghani, Mahdi; Guo, Zhiyun et al. (2018) An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk. Neurobiol Aging 66:178.e1-178.e8
Roe, Catherine M; Babulal, Ganesh M; Mishra, Shruti et al. (2018) Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease. J Alzheimers Dis 61:509-513

Showing the most recent 10 out of 911 publications